Created: 2005-04-07 17:28:43.0
Modified: 2010-03-09 08:27:29.0
Lexi-PALS TM © (1977)-(2007) Lexi-Comp, Inc. All rights reserved.
Vaccine Information Statements (VIS) are developed by the staff of the Centers for Disease Control and Prevention (CDC). Each VIS provides information to properly inform the adult vaccinee or, in the case of a minor, the child's parent or legal representative about the risks and benefits of each vaccine. Before a healthcare provider vaccinates a child or an adult with a dose of DTaP, Td, MMR, varicella, polio, Hib, hepatitis B, or pneumococcal conjugate vaccine, the provider is required by the National Childhood Vaccine Injury Act to provide a copy of the VIS. VISs are available for other vaccines and may be used to educate patients. Foreign language versions are also available.
The vaccine is a weakened, live form of the yellow fever virus. The vaccine is created by growing the live virus in a lab. The preferred storage method is frozen vials. The vaccine is administered subcutaneously (beneath the skin).
The yellow fever vaccine is not usually given with other vaccines, but it may be given with the hepatitis B vaccine .
WHERE CAN I GET MORE INFORMATION?
National Library of Medicine
http://www.nlm.nih.gov/
Vaccine and Immunizations
Centers for Disease Control and Prevention
http://www.cdc.gov/vaccines/
References:
Children’s Hospital of Philadelphia, Vaccine Information Center website. Available at: http://www.chop.edu/consumer/jsp/division/generic.jsp?id=75740 . Accessed February 4, 2007.
The Directors of Health Promotion and Education website. Available at: http://www.dhpe.org/infect/yellow.html . Accessed February 4, 2007.
Khromava AY, Eidex RB, Weld LH, et al. Yellow Fever Vaccine Safety Working Group. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine. 2005 May 9;23(25):3256-63.
Staples JE, Gershman M, Fischer M. Centers for Disease Control and Prevention (CDC). Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27.
US Department of Health and Human Services, National Immunization Program website. Available at: http://www.cdc.gov/vaccines/ . Accessed March 3, 2008.
Yellow fever vaccine. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated February 2010. Accessed February 19, 2010.
2/19/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Transmission of yellow fever vaccine virus through breast-feeding—Brazil, 2009. Morbidity and Mortality Weekly Report (MMWR). 2010;59(05):130.
The vaccine is a weakened, live form of the yellow fever virus. The vaccine is created by growing the live virus in a lab. The preferred storage method is frozen vials. The vaccine is administered subcutaneously (beneath the skin).
The yellow fever vaccine is not usually given with other vaccines, but it may be given with the hepatitis B vaccine .
To decrease your chance of getting yellow fever, do the following:
An outbreak of yellow fever in the United States is highly unlikely, as the virus is not geographically present. But in the event of an outbreak, uninfected individuals would be vaccinated and precautions would be taken to reduce transmission.
Yellow fever is a virus that is transmitted to humans through mosquito bites.
Jungle yellow fever is transmitted to humans through mosquitoes that have been infected by monkeys carrying the virus.
Urban yellow fever is passed to mosquitoes from infected humans, and the mosquitoes continue to infect other humans by biting them. Yellow fever cannot be passed from human to human.
The yellow fever virus is found only in South America and sub-Saharan Africa. Jungle yellow fever is typically only passed to humans who work or travel in the rain forest. Yellow fever can only be contracted through a bite from a female mosquito.
Risk factors for getting yellow fever include traveling to an area where humans are already infected by the yellow fever virus or where there are contaminated monkeys or mosquitoes that can transmit the virus.
Symptoms for yellow fever include:
More serious complications include:
Symptoms typically begin 3-6 days after infection. Yellow fever is diagnosed with a blood test, but there is no course of treatment for the virus. Doctors usually recommend a long period of bed rest, along with plenty of fluids. Patients should also avoid places where mosquitoes are present to avoid spreading the disease to others.
Illness from yellow fever varies from a self-limited illness to hemorrhagic fever, which can be very severe and lead to death.
The following individuals should get vaccinated:
The vaccine lasts for 10 years. Every 10 years, a booster is required if you are at risk for contracting yellow fever.
Common minor side effects include:
Rare, serious side effects include:
The vaccine should not be given to: